Compounds and methods for treating autoimmunity
US11052060B2 · kind B2 · utility
0Cited by
22References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 19, 2019 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Mar 19, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.